Logo Image
|Poll|January 16, 2018

Mini Quiz: Motivational Pharmacotherapy

Motivational interviewing can be very useful for addressing patients' ambivalence about psychopharmacologic issues. Take the quiz and learn more.

Which of the following is NOT true of motivational pharmacotherapy?

A. Integrates motivational interviewing and pharmacotherapy into an approach to enhance patients’ participation in treatment
B. Targets patients' ambivalence about engaging in pharmacotherapy
C. Confronts patients' resistance in a didactic way by challenging ideas on meds & providing didactic modules on antidepressants
D. Differs from META by being conducted by prescribers themselves rather than by additional, non-prescribing clinicians
E. Does not substantially increase the duration of the pharmacotherapy sessions

Related Content

Latest CME

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia
Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

View more
Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care
Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

View more
Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia
Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

View more
Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder
Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

View more
Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia
Video

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C

View more